James Gruber
Chief Financial Officer
Replay available
Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Shawn Bridge-Elson
Chief Executive Officer
David Grimpa
Chief Business Officer
Madison El-Sadi
Analyst, B. Riley
Swayam Bakula
Analyst, HC Wainwright
Chase Knickerbocker
Analyst, Craig Holland
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Eton Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.237 Good afternoon, and welcome to the Eaton Pharmaceuticals Third Quarter 2025 Financial 00:00:05.237 -- 00:00:10.704 Results Conference Call. At this time, all participants are in listen-only mode. 00:00:10.704 -- 00:00:15.049 Following the formal remarks, we will open the call up for your questions. 00:00:15.049 -- 00:00:19.434 Please be advised that this call is being recorded at the company's request. 00:00:19.434 -- 00:00:24.621 At this time, I'd like to turn it over to David Grimpa, Chief Business Officer at 00:00:24.621 -- 00:00:28.323 Eaton Pharmaceuticals. Please proceed. 00:00:29.748 -- 00:00:34.994 Thank you, operator. Good afternoon, everyone, and welcome to Eaton's third quarter 2025 00:00:34.994 -- 00:00:39.900 conference call. This afternoon, we issued a press release that outlines the topics we 00:00:39.900 -- 00:00:46.365 plan to discuss on today's call. The release is available on our website, EatonPharma.com. 00:00:46.528 -- 00:00:51.694 Joining me on our call today, we have Sean Bridgelson, our CEO, James Gruber, 00:00:51.694 -- 00:00:57.120 our CFO, and Ipek Trinkas, our chief commercial officer. 00:00:57.120 -- 00:01:01.314 In addition to taking live questions on today's call, we will be answering questions 00:01:01.314 -- 00:01:06.362 that are emailed to us. Investors can send their questions to investorrelations at 00:01:06.362 -- 00:01:08.362 eatonpharma.com. 00:01:08.526 -- 00:01:13.193 Before we begin, I would like to remind everyone that remarks made during the call may 00:01:13.193 -- 00:01:18.241 contain forward-looking statements and involve risks and uncertainties that could cause 00:01:18.241 -- 00:01:24.091 actual results to differ materially from those contained in these forward-looking statements. 0...